NCT03598426View on ClinicalTrials.gov

Conventional Prophylactic Oral Dexamethasone vs Short-course IV Dexamethasone in Paclitaxel Hypersensitivity

PHASE3CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

August 8, 2018

Primary Completion Date

January 7, 2025

Study Completion Date

January 7, 2025

Conditions
Hypersensitivity Reactions
Interventions
DRUG

Dexamethasone

Conventional arm will only use oral dexamethasone as intervention; Short-Course arm will only use intravenous dexamethasone as intervention; Combined arm will use both oral and intravenous dexamethasone as intervention

Trial Locations (1)

92354

Loma Linda University Cancer Center, Loma Linda

All Listed Sponsors
lead

Loma Linda University

OTHER

NCT03598426 - Conventional Prophylactic Oral Dexamethasone vs Short-course IV Dexamethasone in Paclitaxel Hypersensitivity | Biotech Hunter | Biotech Hunter